RE: The British Government could be facing calls to explain the 'baffling' decision to rely on securing1 Jan 2022 11:45
I also wrote to the editor of the Telegraph on 22 December as follows:
"Hugh Whitfield bemoans the lack of availability of lateral flow tests (letters 21 December), commenting that they are all in warehouses in China. It need not have been this way. About a year ago, the Prime Minister in a press conference said that the government was working day and night to develop the UK diagnostics industry. Subsequent actions suggest otherwise as the following three examples demonstrate.
Abingdon Healthcare is a world leading developer and manufacturer of LFTs. DHSC entered into a contract to purchase LFTs, which were supplied and used as anticipated. However, the government is currently refusing to pay for them.
Omega Diagnostics, another LFT manufacturer, was awarded funds by DHSC to ramp up production capacity, which it did. However, no contract to manufacture has been awarded and DHSC has now demanded the money back.
Finally, Avacta Group has developed what is probably the world’s most accurate LFT and has submitted details for the government’s desktop review (CTDA Regulations) in order to have approval for sale in the UK. The government indicated that the review should take no more than 20 days. Despite submission of all details in August, approval is still awaited.
Far from working to develop the UK diagnostics industry, the government seems determined to destroy it."
The letter was for publication, but has not been used.